Domestic pharmaceutical firms will likely lose momentum under proposed quantity-price linkage system

The government's plan to introduce a system of linking the quantity and quantity of drugs in evaluating drugs to be covered by national insurance will result in discouraging local pharmaceutical firms' will to develop new drugs due to more uncertain business prospect, according to the Korea Pharmaceutical Manufacturers Association (KPMA).

The quantity-price linkage system refers to restricti...